The CE-marked, FDA-listed IDS i20 from Revvity helps laboratories consolidate multiple specialty tests on a unique single instrument. This versatile platform enables the full automation of chemiluminescence immunoassay (ChLIA) processing and allows users to simultaneously run 20 analytes from six diagnostic specialties, including assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer’s disease, and therapeutic drug monitoring. As a high-throughput solution, it has the ability to process up to 140 tests per hour (assay dependent), and can provide reduced hands-on time with integrated cooling of ready-to-use reagent cartridges and onboard storage of consumables. Its software and graphical user interface (GUI) are designed to meet the latest standards of ergonomics, usability, and cybersecurity.